Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 2nd Annual Congress on Bacterial, Viral and Infectious Diseases Dubai, UAE.

Day 2 :

Keynote Forum

Stef Stienstra

Dutch ArmedForces, The Netherlands

Keynote: Drug delivery by tattooing to treat cutaneous leishmaniasis

Time : 09:00-09:40

Conference Series Bacterial Diseases 2019 International Conference Keynote Speaker Stef Stienstra photo
Biography:

Stef Stienstra has been working internationally for several medical and biotech companies as Scientific Advisory Board Member and is also
an active Reserve-Officer of the Royal Dutch Navy in his rank as Commander (OF4). He is a Visiting Professor for the University of Rome Tor Vergata in Italy and Lecturer for the NATO School in Oberammergau in Germany

Abstract:

Leishmaniasis is a vector-borne disease that is caused by obligate intra-macrophage protozoa of the Leishmania species. Leishmaniasis can cause different clinical syndromes, including Cutaneous Leishmaniasis (CL) in which the patient generally presents with one or several ulcer(s) or nodule(s) on the skin, resulting from the infection of phagocytic cells located in the dermis. It often results into severe scar tissue in the skin. Most of the twelve million people infected with Leishmania worldwide are CL cases, a 1.5 million new cases occur annually. WHO has a program to develop new treatments for cutaneous leishmaniasis. This study establishes a proof-of-concept that a tattoo device can target intra-dermal drug delivery against Cutaneous Leishmaniasis (CL). The selected drug is Oleylphosphocholine (OlPC) formulated as liposomes, particles known to be prone to macrophage ingestion. First is shown that treatment of cultured Leishmania-infected macrophages with OlPC-liposomes results in a direct dose-dependent killing of intracellular parasites. Based on this, in vivo efficacy is demonstrated using a 10-day tattooing-mediated treatment in mice infected with L. major and L. mexicana. In both models this regimen results in rapid clinical recovery with complete regression of skin lesions by Day 28. Parasite counts and histopathology examination confirm high treatment efficacy at the parasitic level

Keynote Forum

Mohamad Miqdady

Sheikh Khalifa Medical City, UAE

Keynote: Congenital diarrhea syndromes

Time : 09:40-10:20

Conference Series Bacterial Diseases 2019 International Conference Keynote Speaker Mohamad Miqdady photo
Biography:

Mohamad Miqdady is American Board certified in Pediatric Gastroenterology, Hepatology and Nutrition. He is the Division Chief, Ped. GI, Hepatology & Nutrition Division at Sheikh Khalifa Medical City in UAE. Program Director, Pediatric Gastroenterology Fellowship Training program, SKMC, Abu Dhabi, UAE. Also an Adjunct Staff at Cleveland Clinic, Ohio USA. Expert member of the FISPGHAN Council (Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition); Malnutrition/Obesity Expert team.He completed his Fellowship in Pediatric Gastroenterology at Baylor College of Medicine and Texas Children’s Hospital in Houston, TX, USA. He held the
position of Assistant Professor at Jordan University of Science and Technology in Jordan for six years prior joining SKMC.Main research interests include nutritional disorders, feeding difficulties, picky eating, obesity, procedural sedation, allergic GI disorders and celiac disease. He has 20 publications in peer reviewed journals

 

Abstract:

Congenital diarrhea is a term used to describe diarrhea that develops early in life, typically, within the first two months of life classically associated with dehydration, failure to thrive and electrolyte disturbances. Some of these infants with secretary type might have prenatal findings of dilated bowel loops. While in infants with malabsorptive type it starts with the first feed. The diagnosis is usually established with endoscopic biopsies with electron microscopy evaluation and the appropriate genetic testing. While it might be puzzling and challenging even to the most prudent physician, we will discuss a practical approach that allows you to
have a provisional working diagnosis and management plan helping your infant to back on track in a timely approach. Treatment is usually with long term parenteral nutrition with special attention to avoid long term complication associated with TPN.

Break: 10:20-10:50 Networking and Refreshments Break
  • Workshop
Location: Conference Hall
Speaker
Biography:

Robert O Young is currently working as a Professor at Capital University in Washington, DC. He has completed his MS in Nutrition from the American College in Birmingham, Alabama and DSc with emphasis in Chemistry and Biology and also s PhD from Clayton College of Natural Health.

Abstract:

CF and PAC patients suffer from frequent lung infections that may lead to obstructed breathing caused by an
acidic lifestyle and diet. So, the mainstays of a treatment plan are:
1. Open up the channels of elimination of dietary and metabolic acids.
2. Hyper-perfuse the blood, interstitial fluids and the intracellular fluids with alkalinity to buffer the
retained dietary and/or metabolic acids in the organs, glands and tissues.
3. Heal the root system or bowels of the body or the intestinal villi of the small intestines to improve the
quality and quantity of stem cell and red blood cell production
4. Alkalizing physical therapy to remove acids out of the interstitial fluids and intracellular fluids of the
tissues, especially the lungs.
5. Alkalizing exercise to remove dietary and/or metabolic acids in the blood plasma, interstitial
compartments of the Interstitium, and finally the connective tissues out through the pores of the skin.
6. Alkalizing natural organic and colloidal natural medications for reducing the acids that cause mucus that
is congesting and blocking the lung's airways.

 

  • Epidemiology of Re-Emerging Infectious Diseases | Causes, Symptoms and Diagnosis of Infectious Diseases | Advances in Antimicrobials, Vaccines and Therapeutics | Bacterial and Viral Genomics | Case Studies | Antiviral, Antibacterial, Antifungal Agents | Clinical Case Reports
Location: Dubai
Speaker

Chair

Robert O Young

PH Miracle Centre, USA

Co-Chair

Hoda Mansour

GHD/EMPHNET Contractor, Egypt

Speaker
Biography:

Robert O Young is currently working as a Professor at Capital University in Washington, DC. He has completed his MS in Nutrition from the American College in Birmingham, Alabama and DSc with emphasis in Chemistry and Biology and also s PhD from Clayton
College of Natural Health.

Abstract:

CF and PAC patients suffer from frequent lung infections that may lead to obstructed breathing caused by an
acidic lifestyle and diet. So, the mainstays of a treatment plan are:
1. Open up the channels of elimination of dietary and metabolic acids.
2. Hyper-perfuse the blood, interstitial fluids and the intracellular fluids with alkalinity to buffer the
retained dietary and/or metabolic acids in the organs, glands and tissues.
3. Heal the root system or bowels of the body or the intestinal villi of the small intestines to improve the quality and quantity of stem cell and red blood cell production
4. Alkalizing physical therapy to remove acids out of the interstitial fluids and intracellular fluids of the tissues, especially the lungs.
5. Alkalizing exercise to remove dietary and/or metabolic acids in the blood plasma, interstitial compartments of the Interstitium, and finally the connective tissues out through the pores of the skin.
6. Alkalizing natural organic and colloidal natural medications for reducing the acids that cause mucus that is congesting and blocking the lung's airways.

Sivasankari Murugan

Meenakshi Medical College Hospital and Research Institute, India

Title: Resistogram pattern of Escherichia coli isolated from various clinical samples in & around Kanchipuram

Time : 11:50-12:20

Speaker
Biography:

S. Sivasankari has completed MBBS from Rajah Muthiah Medical College and Post graduation MD (Microbiology) from Madras University, Tamil Nadu, India. She is Associate Professor in Microbiology at Meenakshi Medical College & RI, Kanchipuram, Tamil Nadu, India. She has published more than 30 research papers in reputed journals. Her areas of interest include Hospital Infection Control, Anti Microbial resistance surveillance . Under gone training in NABL & NABH accreditation courses & Currently working as NABH Co-ordinator.

Abstract:

E.coli is one of the main cause of nosocomial infection in humans. E.coli being one of the common organism causing hospital acquired infections exhibits ESBL production Causing resistant to Beta lactam group of drugs resulting in limited treatment options. Hence, this study was done to know the resistance pattern in E.coli and their virulence factors. Materials and Methods: Samples (urine, pus, sputum) were collected & processed as per standard protocols E.coli were isolated. Antibiogram done as per CLSI guidelines. ESBL & MBL screening done, Biofilm formation of E.coli was studied in correlation to antibiotic resistance. Result: 235 E.coli were isolated from various clinical samples. Out of 235, 148 (62.97%) showed resistance to ceftazidime & cefatoxime, 53 (22.55%) were ESBL producers, 19 (8.8%) showed resistance to imipenem, 32 (1.27%) were MBL producer. E.coli were resistant to nalidixic acid, 119 (50.6%) followed by Cotrimoxazole 98(41.7%), Ciprofloxacin resistance was 135 (57.6%) and MIC ranged from 8- 64 μg/ml. Among 235 E.coli isolates 169 (46.38%) were MDR of which 29 (12.34%) were strong biofilm producers. Conclusion: This study highlights that all isolated ESBL producers were resistant to 3rd Gen. cephalosporins. This increase in resistance to number of commonly used antibiotics shows the emerging drug resistance. In view of this, ESBL testing and MBL screening should be made as a routine testing which will help in the shuffling of antibiotics and for proper treatment and to prevent further development of bacterial drug resistance

Speaker
Biography:

S Senthamarai has completed her MD in Microbiology from Stanley Medical College. She is currently working as Professor in Meenakshi Medical College Hospital and Research Institute, India. Her areas of interest are Mycology, HIV, Antibiotic Resistance, Infection Control and Medical Education. She has received the Medical Excellence Award by Indian Solitarity Council at New Delhi and also has won many best paper awards to her credit. She has published more than 30 articles in reputed journals

Abstract:

Coagulase Negative Staphylococci (CoNS) are now emerging as important pathogen and its resistance to antibiotics are worrisome. Methicillin resistance among CoNS causes an important therapeutic threat associated with increased morbidity and mortality. This study was aimed to isolate the coagulase negative Staphylococci from various clinical specimens, evaluate its antibioticsusceptibility pattern and to detect the prevalence of mecA gene among coagulase negative Staphylococci.All the clinical samples were collected with aseptic precautions and processed as per standard protocol. All the coagulase negative Staphylococcal isolates were subjected for antibiotic susceptibility testing as per CLSI guidelines. Screening of methicillin resistance was done using cefoxitin disc (30 μg) as per CLSI recommended disc diffusion method. Genotypic analysis for methicillin resistance (mecA gene) was done.

Break: Lunch Break 12:50-13:50 @ Restaurant
Speaker
Biography:

Prashanthi Rayapati is currently pursuing her High School at LYNBROOK HIGH SCHOOL, San Jose, CA. Her Research of interests are Evolutionary Cell Biology research in gene modifications using DNA methods, Cognitive Artificial Intelligence modeling of Duchenne Muscular Dystrophy using the C.elegans effect on G.Lucidium on the Life Span of Patients. She got awards like Shri Krupa Volunteer of the Year, Synopsis Science Fair Honorable Mention, Leukemia and Lymphoma Society Award, JEENA recognition Award.

 

Abstract:

Duchenne muscular dystrophy (DMD) is an X chromosome-linked disease characterized by progressive physical disability, immobility and premature death in affected boys. Underlying the devastating symptoms of DMD is the loss of dystrophin, a structural protein that connects the extracellular matrix to the cell cytoskeleton and provides protection against contraction-induced damage in muscle cells, leading to chronic peripheral inflammation. However, dystrophin is expressed in neurons within specific brain regions, including the hippocampus, a structure associated with learning and memory formation. Linked to this, a subset of boys with DMD exhibit progressing cognitive dysfunction, with deficits in verbal, short-term, and working memory. Furthermore, in the genetically comparable dystrophin-deficient mouse model of DMD, some, but not all, types of learning and memory are deficient, and specific deficits in synaptogenesis and channel clustering at synapses has been noted. Little consideration has been given to the cognitive deficits associated with DMD compared with the research conducted into the peripheral effects of dystrophin deficiency. Therefore, this review focuses on what is known about the role of full-length dystrophin (Dp427) in the hippocampal neurons. In this experiment, I hypothesized that 100 ug/ml of G. Lucidum would extend the lifespan and too much concentration of this herbal medicine would lose its efficacy in treating this disease.

Speaker
Biography:

C Anitha has completed her PhD from Dr ALM PGIBMS, University of Madras, India. She is currently working as Assistant Professor of Microbiology in Meenakshi Medical College Hospital and Research Institute. Her areas of interest are Biofilm studies using Confocal Laser Scanning Microscope, Antimicrobial resistance and rare Infectious diseases. She has published more than 30 papers in reputed journals and also has 15 Data sequences submitted in PUBMED/NCBI Genebank. She is also serving as an Editor, Associate Editor, Editorial Board Member and Review Board Member of reputed journals.

Abstract:

Introduction & Objective: Recent studies had showed that Mesenchymal Stem Cells (MSCs) have beneficial effects on bacterial infections. Treatment with MSCs has proven bacterial clearance. This study was undertaken to study the in vitro activity of antimicrobial and antibiofilm activity of stems cells against gram negative multidrug resistant organism from urinary tract infections.Method: The samples will be processed according to standard protocol following standard guidelines. All the isolates obtained will be identified by standard guidelines. Total of 50 isolates were collected. The antibiotic susceptibility testing will be done for all the isolates by Kirby Bauer disc diffusion method following CLSI guidelines. All the isolates are screened for production of biofilm by tissue culture plate method. The antimicrobial activity of mesenchymal stem cells was done by micro broth dilution method.

Break: 14:50-15:20 Networking and Refreshments Break
Biography:

C Anitha has completed her PhD from Dr ALM PGIBMS, University of Madras, India. She is currently working as Assistant Professor of Microbiology in Meenakshi Medical College Hospital and Research Institute. Her areas of interest are Biofilm studies using Confocal Laser Scanning Microscope, Antimicrobial resistance and rare Infectious diseases. She has published more than 30 papers in reputed journals and also has 15 Data sequences submitted in PUBMED/NCBI Genebank. She is also serving as an Editor, Associate Editor, Editorial Board
Member and Review Board Member of reputed journals.

Abstract:

Introduction & Objective: Recent studies had showed that Mesenchymal Stem Cells (MSCs) have beneficial effects on bacterial infections. Treatment with MSCs has proven bacterial clearance. This study was undertaken to study the in vitro activity of antimicrobial and antibiofilm activity of stems cells against gram negative multidrug resistant organism from urinary tract infections.Method: The samples will be processed according to standard protocol following standard guidelines. All the isolates obtained will be identified by standard guidelines. Total of 50 isolates were collected. The
antibiotic susceptibility testing will be done for all the isolates by Kirby Bauer disc diffusion method following CLSI guidelines. All the isolates are screened for production of biofilm by tissue culture plate method. The antimicrobial activity of mesenchymal stem cells was done by micro broth dilution method.

  • Poster Presentations
Location: Conference Hall